Biomaterial integration in the joint: pathological considerations, immunomodulation, and the extracellular matrix

HIGHLIGHTS

• who: von Mentzer and collaborators from the researchchalmersse offers the possibility of retrieving research publications produced at Chalmers University of have published the research: Biomaterial Integration in the Joint: Pathological Considerations, Immunomodulation, and the Extracellular Matrix, in the Journal: (JOURNAL)
• what: The aim of this review is therefore to summarize important organ and tissue specific features and highlight pathological and immune-related mechanisms that biomaterials face in patients with OA and RA .
• future: Fibronectin III domains potently induce aggrecanase activity by signaling through TLR 4 which further contribute to cartilage degradation.[209] However . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.